Global RNAi Therapy Market Growth (Status and Outlook) 2026-2032

May 2026 | 86 pages | ID: G7805395BCDFEN
LP Information

Abstracts

The global RNAi Therapy market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

RNAi Therapy is a new treatment method that uses RNA interference (RNA interference, RNAi) to treat diseases. RNA interference refers to the introduction of double-stranded RNA molecules, so that the mRNA molecules of a specific gene cannot be translated into proteins, thereby achieving the purpose of inhibiting the expression of the gene. RNAi therapy utilizes the human body's own gene regulation mechanism. It has strong targeting, good therapeutic effect, and few side effects. It is a new type of treatment with great potential.

United States market for RNAi Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for RNAi Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for RNAi Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key RNAi Therapy players cover Alnylam, Sarepta Therapeutics, Alnylam Pharmaceuticals, Moderna, Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the “RNAi Therapy Industry Forecast” looks at past sales and reviews total world RNAi Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected RNAi Therapy sales for 2026 through 2032. With RNAi Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world RNAi Therapy industry.

This Insight Report provides a comprehensive analysis of the global RNAi Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on RNAi Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global RNAi Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for RNAi Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global RNAi Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of RNAi Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Small Molecule Interfering Ribonucleic Acid (SiRNA)
• Microrna (MiRNA)

Segmentation by Application:

• Oncology
• Cardiology
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Alnylam
• Sarepta Therapeutics
• Alnylam Pharmaceuticals
• Moderna
• Sanofi
• Arcturus Therapeutics
• Silence
• Sirnaomics

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global RNAi Therapy Market Size (2021-2032)
  2.1.2 RNAi Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for RNAi Therapy by Country/Region (2021, 2025 & 2032)
2.2 RNAi Therapy Segment by Type
  2.2.1 Small Molecule Interfering Ribonucleic Acid (SiRNA)
  2.2.2 Microrna (MiRNA)
  2.2.3 RNAi Therapy Market Size by Type
    2.2.3.1 RNAi Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global RNAi Therapy Market Size Market Share by Type (2021-2026)
2.3 RNAi Therapy Segment by Application
  2.3.1 Oncology
  2.3.2 Cardiology
  2.3.3 Others
  2.3.4 RNAi Therapy Market Size by Application
    2.3.4.1 RNAi Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global RNAi Therapy Market Size Market Share by Application (2021-2026)

3 RNAI THERAPY MARKET SIZE BY PLAYER

3.1 RNAi Therapy Market Size Market Share by Player
  3.1.1 Global RNAi Therapy Revenue by Player (2021-2026)
  3.1.2 Global RNAi Therapy Revenue Market Share by Player (2021-2026)
3.2 Global RNAi Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RNAI THERAPY BY REGION

4.1 RNAi Therapy Market Size by Region (2021-2026)
4.2 Global RNAi Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas RNAi Therapy Market Size Growth (2021-2026)
4.4 APAC RNAi Therapy Market Size Growth (2021-2026)
4.5 Europe RNAi Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa RNAi Therapy Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas RNAi Therapy Market Size by Country (2021-2026)
5.2 Americas RNAi Therapy Market Size by Type (2021-2026)
5.3 Americas RNAi Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC RNAi Therapy Market Size by Region (2021-2026)
6.2 APAC RNAi Therapy Market Size by Type (2021-2026)
6.3 APAC RNAi Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe RNAi Therapy Market Size by Country (2021-2026)
7.2 Europe RNAi Therapy Market Size by Type (2021-2026)
7.3 Europe RNAi Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa RNAi Therapy by Region (2021-2026)
8.2 Middle East & Africa RNAi Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa RNAi Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RNAI THERAPY MARKET FORECAST

10.1 Global RNAi Therapy Forecast by Region (2027-2032)
  10.1.1 Global RNAi Therapy Forecast by Region (2027-2032)
  10.1.2 Americas RNAi Therapy Forecast
  10.1.3 APAC RNAi Therapy Forecast
  10.1.4 Europe RNAi Therapy Forecast
  10.1.5 Middle East & Africa RNAi Therapy Forecast
10.2 Americas RNAi Therapy Forecast by Country (2027-2032)
  10.2.1 United States Market RNAi Therapy Forecast
  10.2.2 Canada Market RNAi Therapy Forecast
  10.2.3 Mexico Market RNAi Therapy Forecast
  10.2.4 Brazil Market RNAi Therapy Forecast
10.3 APAC RNAi Therapy Forecast by Region (2027-2032)
  10.3.1 China RNAi Therapy Market Forecast
  10.3.2 Japan Market RNAi Therapy Forecast
  10.3.3 Korea Market RNAi Therapy Forecast
  10.3.4 Southeast Asia Market RNAi Therapy Forecast
  10.3.5 India Market RNAi Therapy Forecast
  10.3.6 Australia Market RNAi Therapy Forecast
10.4 Europe RNAi Therapy Forecast by Country (2027-2032)
  10.4.1 Germany Market RNAi Therapy Forecast
  10.4.2 France Market RNAi Therapy Forecast
  10.4.3 UK Market RNAi Therapy Forecast
  10.4.4 Italy Market RNAi Therapy Forecast
  10.4.5 Russia Market RNAi Therapy Forecast
10.5 Middle East & Africa RNAi Therapy Forecast by Region (2027-2032)
  10.5.1 Egypt Market RNAi Therapy Forecast
  10.5.2 South Africa Market RNAi Therapy Forecast
  10.5.3 Israel Market RNAi Therapy Forecast
  10.5.4 Turkey Market RNAi Therapy Forecast
10.6 Global RNAi Therapy Forecast by Type (2027-2032)
10.7 Global RNAi Therapy Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market RNAi Therapy Forecast

11 KEY PLAYERS ANALYSIS

11.1 Alnylam
  11.1.1 Alnylam Company Information
  11.1.2 Alnylam RNAi Therapy Product Offered
  11.1.3 Alnylam RNAi Therapy Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Alnylam Main Business Overview
  11.1.5 Alnylam Latest Developments
11.2 Sarepta Therapeutics
  11.2.1 Sarepta Therapeutics Company Information
  11.2.2 Sarepta Therapeutics RNAi Therapy Product Offered
  11.2.3 Sarepta Therapeutics RNAi Therapy Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Sarepta Therapeutics Main Business Overview
  11.2.5 Sarepta Therapeutics Latest Developments
11.3 Alnylam Pharmaceuticals
  11.3.1 Alnylam Pharmaceuticals Company Information
  11.3.2 Alnylam Pharmaceuticals RNAi Therapy Product Offered
  11.3.3 Alnylam Pharmaceuticals RNAi Therapy Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Alnylam Pharmaceuticals Main Business Overview
  11.3.5 Alnylam Pharmaceuticals Latest Developments
11.4 Moderna
  11.4.1 Moderna Company Information
  11.4.2 Moderna RNAi Therapy Product Offered
  11.4.3 Moderna RNAi Therapy Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Moderna Main Business Overview
  11.4.5 Moderna Latest Developments
11.5 Sanofi
  11.5.1 Sanofi Company Information
  11.5.2 Sanofi RNAi Therapy Product Offered
  11.5.3 Sanofi RNAi Therapy Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Sanofi Main Business Overview
  11.5.5 Sanofi Latest Developments
11.6 Arcturus Therapeutics
  11.6.1 Arcturus Therapeutics Company Information
  11.6.2 Arcturus Therapeutics RNAi Therapy Product Offered
  11.6.3 Arcturus Therapeutics RNAi Therapy Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Arcturus Therapeutics Main Business Overview
  11.6.5 Arcturus Therapeutics Latest Developments
11.7 Silence
  11.7.1 Silence Company Information
  11.7.2 Silence RNAi Therapy Product Offered
  11.7.3 Silence RNAi Therapy Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Silence Main Business Overview
  11.7.5 Silence Latest Developments
11.8 Sirnaomics
  11.8.1 Sirnaomics Company Information
  11.8.2 Sirnaomics RNAi Therapy Product Offered
  11.8.3 Sirnaomics RNAi Therapy Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Sirnaomics Main Business Overview
  11.8.5 Sirnaomics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. RNAi Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. RNAi Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Small Molecule Interfering Ribonucleic Acid (SiRNA)
Table 4. Major Players of Microrna (MiRNA)
Table 5. RNAi Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global RNAi Therapy Market Size by Type (2021-2026) & ($ millions)
Table 7. Global RNAi Therapy Market Size Market Share by Type (2021-2026)
Table 8. RNAi Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global RNAi Therapy Market Size by Application (2021-2026) & ($ millions)
Table 10. Global RNAi Therapy Market Size Market Share by Application (2021-2026)
Table 11. Global RNAi Therapy Revenue by Player (2021-2026) & ($ millions)
Table 12. Global RNAi Therapy Revenue Market Share by Player (2021-2026)
Table 13. RNAi Therapy Key Players Head office and Products Offered
Table 14. RNAi Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global RNAi Therapy Market Size by Region (2021-2026) & ($ millions)
Table 18. Global RNAi Therapy Market Size Market Share by Region (2021-2026)
Table 19. Global RNAi Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global RNAi Therapy Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas RNAi Therapy Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas RNAi Therapy Market Size Market Share by Country (2021-2026)
Table 23. Americas RNAi Therapy Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas RNAi Therapy Market Size Market Share by Type (2021-2026)
Table 25. Americas RNAi Therapy Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas RNAi Therapy Market Size Market Share by Application (2021-2026)
Table 27. APAC RNAi Therapy Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC RNAi Therapy Market Size Market Share by Region (2021-2026)
Table 29. APAC RNAi Therapy Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC RNAi Therapy Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe RNAi Therapy Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe RNAi Therapy Market Size Market Share by Country (2021-2026)
Table 33. Europe RNAi Therapy Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe RNAi Therapy Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa RNAi Therapy Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa RNAi Therapy Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa RNAi Therapy Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of RNAi Therapy
Table 39. Key Market Challenges & Risks of RNAi Therapy
Table 40. Key Industry Trends of RNAi Therapy
Table 41. Global RNAi Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global RNAi Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global RNAi Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global RNAi Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Alnylam Details, Company Type, RNAi Therapy Area Served and Its Competitors
Table 46. Alnylam RNAi Therapy Product Offered
Table 47. Alnylam RNAi Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Alnylam Main Business
Table 49. Alnylam Latest Developments
Table 50. Sarepta Therapeutics Details, Company Type, RNAi Therapy Area Served and Its Competitors
Table 51. Sarepta Therapeutics RNAi Therapy Product Offered
Table 52. Sarepta Therapeutics RNAi Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Sarepta Therapeutics Main Business
Table 54. Sarepta Therapeutics Latest Developments
Table 55. Alnylam Pharmaceuticals Details, Company Type, RNAi Therapy Area Served and Its Competitors
Table 56. Alnylam Pharmaceuticals RNAi Therapy Product Offered
Table 57. Alnylam Pharmaceuticals RNAi Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Alnylam Pharmaceuticals Main Business
Table 59. Alnylam Pharmaceuticals Latest Developments
Table 60. Moderna Details, Company Type, RNAi Therapy Area Served and Its Competitors
Table 61. Moderna RNAi Therapy Product Offered
Table 62. Moderna RNAi Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Moderna Main Business
Table 64. Moderna Latest Developments
Table 65. Sanofi Details, Company Type, RNAi Therapy Area Served and Its Competitors
Table 66. Sanofi RNAi Therapy Product Offered
Table 67. Sanofi RNAi Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Sanofi Main Business
Table 69. Sanofi Latest Developments
Table 70. Arcturus Therapeutics Details, Company Type, RNAi Therapy Area Served and Its Competitors
Table 71. Arcturus Therapeutics RNAi Therapy Product Offered
Table 72. Arcturus Therapeutics RNAi Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Arcturus Therapeutics Main Business
Table 74. Arcturus Therapeutics Latest Developments
Table 75. Silence Details, Company Type, RNAi Therapy Area Served and Its Competitors
Table 76. Silence RNAi Therapy Product Offered
Table 77. Silence RNAi Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Silence Main Business
Table 79. Silence Latest Developments
Table 80. Sirnaomics Details, Company Type, RNAi Therapy Area Served and Its Competitors
Table 81. Sirnaomics RNAi Therapy Product Offered
Table 82. Sirnaomics RNAi Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Sirnaomics Main Business
Table 84. Sirnaomics Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. RNAi Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global RNAi Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. RNAi Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. RNAi Therapy Sales Market Share by Country/Region (2025)
Figure 8. RNAi Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global RNAi Therapy Market Size Market Share by Type in 2025
Figure 10. RNAi Therapy in Oncology
Figure 11. Global RNAi Therapy Market: Oncology (2021-2026) & ($ millions)
Figure 12. RNAi Therapy in Cardiology
Figure 13. Global RNAi Therapy Market: Cardiology (2021-2026) & ($ millions)
Figure 14. RNAi Therapy in Others
Figure 15. Global RNAi Therapy Market: Others (2021-2026) & ($ millions)
Figure 16. Global RNAi Therapy Market Size Market Share by Application in 2025
Figure 17. Global RNAi Therapy Revenue Market Share by Player in 2025
Figure 18. Global RNAi Therapy Market Size Market Share by Region (2021-2026)
Figure 19. Americas RNAi Therapy Market Size 2021-2026 ($ millions)
Figure 20. APAC RNAi Therapy Market Size 2021-2026 ($ millions)
Figure 21. Europe RNAi Therapy Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa RNAi Therapy Market Size 2021-2026 ($ millions)
Figure 23. Americas RNAi Therapy Value Market Share by Country in 2025
Figure 24. United States RNAi Therapy Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada RNAi Therapy Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico RNAi Therapy Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil RNAi Therapy Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC RNAi Therapy Market Size Market Share by Region in 2025
Figure 29. APAC RNAi Therapy Market Size Market Share by Type (2021-2026)
Figure 30. APAC RNAi Therapy Market Size Market Share by Application (2021-2026)
Figure 31. China RNAi Therapy Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan RNAi Therapy Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea RNAi Therapy Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia RNAi Therapy Market Size Growth 2021-2026 ($ millions)
Figure 35. India RNAi Therapy Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia RNAi Therapy Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe RNAi Therapy Market Size Market Share by Country in 2025
Figure 38. Europe RNAi Therapy Market Size Market Share by Type (2021-2026)
Figure 39. Europe RNAi Therapy Market Size Market Share by Application (2021-2026)
Figure 40. Germany RNAi Therapy Market Size Growth 2021-2026 ($ millions)
Figure 41. France RNAi Therapy Market Size Growth 2021-2026 ($ millions)
Figure 42. UK RNAi Therapy Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy RNAi Therapy Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia RNAi Therapy Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa RNAi Therapy Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa RNAi Therapy Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa RNAi Therapy Market Size Market Share by Application (2021-2026)
Figure 48. Egypt RNAi Therapy Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa RNAi Therapy Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel RNAi Therapy Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey RNAi Therapy Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries RNAi Therapy Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas RNAi Therapy Market Size 2027-2032 ($ millions)
Figure 54. APAC RNAi Therapy Market Size 2027-2032 ($ millions)
Figure 55. Europe RNAi Therapy Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa RNAi Therapy Market Size 2027-2032 ($ millions)
Figure 57. United States RNAi Therapy Market Size 2027-2032 ($ millions)
Figure 58. Canada RNAi Therapy Market Size 2027-2032 ($ millions)
Figure 59. Mexico RNAi Therapy Market Size 2027-2032 ($ millions)
Figure 60. Brazil RNAi Therapy Market Size 2027-2032 ($ millions)
Figure 61. China RNAi Therapy Market Size 2027-2032 ($ millions)
Figure 62. Japan RNAi Therapy Market Size 2027-2032 ($ millions)
Figure 63. Korea RNAi Therapy Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia RNAi Therapy Market Size 2027-2032 ($ millions)
Figure 65. India RNAi Therapy Market Size 2027-2032 ($ millions)
Figure 66. Australia RNAi Therapy Market Size 2027-2032 ($ millions)
Figure 67. Germany RNAi Therapy Market Size 2027-2032 ($ millions)
Figure 68. France RNAi Therapy Market Size 2027-2032 ($ millions)
Figure 69. UK RNAi Therapy Market Size 2027-2032 ($ millions)
Figure 70. Italy RNAi Therapy Market Size 2027-2032 ($ millions)
Figure 71. Russia RNAi Therapy Market Size 2027-2032 ($ millions)
Figure 72. Egypt RNAi Therapy Market Size 2027-2032 ($ millions)
Figure 73. South Africa RNAi Therapy Market Size 2027-2032 ($ millions)
Figure 74. Israel RNAi Therapy Market Size 2027-2032 ($ millions)
Figure 75. Turkey RNAi Therapy Market Size 2027-2032 ($ millions)
Figure 76. Global RNAi Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global RNAi Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries RNAi Therapy Market Size 2027-2032 ($ millions)